Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Wednesday, April 24, 2024 · 706,072,200 Articles · 3+ Million Readers

Forging Ahead with a New Class of Antibiotics

Superbugs USA 2017

Superbugs USA 2017

Novel solutions in antibiotic drug discovery showcased by Forge Therapeutics, CARB-X and ContraFect at North American Superbugs Summit this Fall

....we risk endemic outbreaks of multidrug resistant bacteria, and a worst case scenario of a return to the pre-antibiotic era”
— CEO, DeNovaMed Inc
ISELIN, NEW JERSEY, UNITED KINGDOM, July 25, 2017 /EINPresswire.com/ -- SMi Group are delighted to announce that Zachary Zimmerman, CEO of Forge Therapeutics, has been added onto the agenda for Superbugs USA when it returns to Iselin, New Jersey this fall.

Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins.

With over 15 years of experience, Dr. Zimmerman is a trained cellular biologist with expertise in drug discovery and development. Highlights from his talk will include innovative insight into effective metalloenzyme inhibitors and discussions surrounding small molecules that inhibit LpxC with broad spectrum against drug resistant bacteria.

Zachery Zimmerman will also discuss funding to advance preclinical development and present proven insight into the IV and oral efficacy in animal infection models.

SMi has been providing a platform for the AMR community to network and consolidate the latest developments in antimicrobial resistance for almost 20 years. The next annual USA summit will continue provide a comprehensive overview of current issues and ongoing considerations to both new and established stakeholders from a notable line-up featuring:

CARB-X, Pfizer, DemovaMed, Visterra, Centauri Therapeutics, MedImmune, Soligenix, ContraFect, Achaogen, Macrolide Pharmaceuticals and more.

Further information including a detailed agenda is available at www.superbugs-usa.com

Superbugs & Superdrugs USA will take place on 13th & 14th November at the Renaissance Woodbrigde Hotel in Iselin, New Jersey. Sponsored by Merck and Soligenix.

--- END ---
Contact Information:

For all media inquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
2078276162
email us here
SMi Group

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release